Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary

  • Tilmann Bochtler
  • , Anna Reiling
  • , Volker Endris
  • , Thomas Hielscher
  • , Anna Lena Volckmar
  • , Olaf Neumann
  • , Martina Kirchner
  • , Jan Budczies
  • , Lukas C. Heukamp
  • , Jonas Leichsenring
  • , Michael Allgäuer
  • , Daniel Kazdal
  • , Harald Löffler
  • , Wilko Weichert
  • , Peter Schirmacher
  • , Albrecht Stenzinger
  • , Alwin Krämer

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology